标题
Targeted 5-HT1F Therapies for Migraine
作者
关键词
Migraine treatment, 5-HT<sub>1F</sub>, Migraine, Lasmiditan, LY344864, LY334370
出版物
Neurotherapeutics
Volume 15, Issue 2, Pages 291-303
出版商
Springer Nature
发表日期
2018-02-27
DOI
10.1007/s13311-018-0615-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Lasmiditan for the treatment of migraine
- (2017) Matilde Capi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development
- (2017) Piero Barbanti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine
- (2017) Bianca Raffaelli et al. EXPERT OPINION ON PHARMACOTHERAPY
- Triptans and migraine: advances in use, administration, formulation, and development
- (2017) Amanda E. Macone et al. EXPERT OPINION ON PHARMACOTHERAPY
- An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine
- (2017) Francesca Puledda et al. HEADACHE
- Current and novel insights into the neurophysiology of migraine and its implications for therapeutics
- (2017) Simon Akerman et al. PHARMACOLOGY & THERAPEUTICS
- Pathophysiology of Migraine: A Disorder of Sensory Processing
- (2017) Peter J. Goadsby et al. PHYSIOLOGICAL REVIEWS
- Headache research in 2015: progress in migraine treatment
- (2016) Hans-Christoph Diener et al. LANCET NEUROLOGY
- Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan
- (2014) Paul Rizzoli Neuropsychiatric Disease and Treatment
- The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine
- (2014) Uwe Reuter et al. Therapeutic Advances in Neurological Disorders
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Drugs targeting 5-hydroxytryptamine receptors in acute treatments of migraine attacks. A review of new drugs and new administration forms of established drugs
- (2013) Peer C Tfelt-Hansen et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Activation of 5-hydroxytryptamine1B/1D/1Freceptors as a mechanism of action of antimigraine drugs
- (2013) Martha B Ramírez Rosas et al. EXPERT OPINION ON PHARMACOTHERAPY
- Dihydroergotamine, Ergotamine, Methysergide and Sumatriptan - Basic Science in Relation to Migraine Treatment
- (2012) Carl Dahlöf et al. HEADACHE
- The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials
- (2012) Peer C. Tfelt-Hansen et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
- (2012) Markus Färkkilä et al. LANCET NEUROLOGY
- mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene–related peptide in the rat trigeminovascular system
- (2012) Dipak V. Amrutkar et al. PAIN
- Distribution of 5-HT 1B , 5-HT 1D and 5-HT 1F receptor expression in rat trigeminal and dorsal root ganglia neurons: Relevance to the selective anti-migraine effect of triptans
- (2010) J.D. Classey et al. BRAIN RESEARCH
- 5-Hydroxyptryptamine 1F (5-HT1F) receptor agonism. A possible new treatment principle for acute migraine attacks
- (2010) Jes Olesen CEPHALALGIA
- Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan
- (2010) David L Nelson et al. CEPHALALGIA
- Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan – A randomised proof-of-concept trial
- (2010) Michel D Ferrari et al. CEPHALALGIA
- Colocalization of 5-HT1F receptor and glutamate in neurons of the vestibular nuclei in rats
- (2009) Seong-Ki Ahn et al. NEUROREPORT
- Colocalization of 5-HT1F receptor and calcitonin gene-related peptide in rat vestibular nuclei
- (2009) Seong-Ki Ahn et al. NEUROSCIENCE LETTERS
- The vascular theory of migraine—a great story wrecked by the facts
- (2008) Peter J. Goadsby BRAIN
- History of Methysergide in Migraine
- (2008) PJ Koehler et al. CEPHALALGIA
- History of the Use of Ergotamine and Dihydroergotamine in Migraine From 1906 and Onward
- (2008) PC Tfelt-Hansen et al. CEPHALALGIA
- Sumatriptan Inhibits Synaptic Transmission in the Rat Midbrain Periaqueductal Grey
- (2008) Hyo-Jin Jeong et al. Molecular Pain
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation